Research Topics
Genomes and Genes | A BrilSummaryAffiliation: SmithKline Beecham Pharmaceuticals Country: USA Publications
| Collaborators
|
Detail Information
Publications
Biophysical interaction between phospholamban and protein phosphatase 1 regulatory subunit GMI Berrebi-Bertrand
SmithKline Beecham Laboratoires Pharmaceutiques, Saint Grégoire, France
FEBS Lett 439:224-30. 1998..Thus, the interaction between PLB and GM may represent a specific way to modulate the SR function in human cardiac muscle...
The gamma-subunit of (Na+,K+)-ATPase: a representative example of human single transmembrane protein with a key regulatory roleI Berrebi-Bertran
SmithKline Beecham Laboratoires Pharmaceutiques, Saint Grégoire, France
Cell Mol Biol (Noisy-le-grand) 47:285-96. 2001..These proteins are critical in controlling important biological processes which derive from specific associations with a binding partner and particular subcellular localizations...
Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilideA Bril
SmithKline Beecham Laboratoires Pharmaceutiques, Saint Grégoire, France
Cardiovasc Res 37:130-40. 1998....
Structure of the human glycogen-associated protein phosphatase 1 regulatory subunit hGM: homology modeling revealed an (alpha/beta)8-barrel-like fold in the multidomain proteinM Souchet
SmithKline Beecham Laboratoires Pharmaceutiques, Saint Grégoire, France
Protein Sci 8:2570-9. 1999..This work highlights the presence of a conserved fold among distant species (mammalian, Caenorhabditis elegans, yeast) and, thus, emphasizes the involvement of PP1 in crucial basic cellular functions...
Synthesis, electrophysiological properties and analysis of structural requirements of a novel class of antiarrhythmic agents with potassium and calcium channel blocking propertiesG Nadler
SmithKline Beecham Laboratoires Pharmaceutiques, Saint Grégoire, France
Bioorg Med Chem 6:1993-2011. 1998..New derivatives depicting bell-shaped dose-response curves on action potential duration may therefore represent novel agents for improved antiarrhythmic therapy...
Inhibition of the cardiac electrogenic sodium bicarbonate cotransporter reduces ischemic injuryN Khandoudi
GlaxoSmithKline Laboratoires Pharmaceutiques, 4 rue du Chesnay Beauregard, BP 96205, 35762 Cédex, Saint Grégoire, France
Cardiovasc Res 52:387-96. 2001..However, Na(+)-driven HCO(-)(3) transport, which is quantitatively as important as NHE in cardiac cells, has not been examined...
Identification and characterization of cvHsp. A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissuesS Krief
SmithKline Beecham Laboratoires Pharmaceutiques, 4 rue du Chesnay Beauregard, BP 58, 35762 Saint Grégoire, France
J Biol Chem 274:36592-600. 1999..Within cvHsp, amino acid residues 56-119 were shown to be important for its specific interaction with the C-terminal tail of alpha-filamin...
Cloning and characterization of a human electrogenic Na+-HCO-3 cotransporter isoform (hhNBC)I Choi
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Am J Physiol 276:C576-84. 1999..We conclude that hhNBC is an electrogenic Na+-HCO-3 cotransporter and that hkNBC is also electrogenic...
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytesP Robert
GlaxoSmithKline Laboratoires Pharmaceutiques, 4 rue du Chesnay Beauregard, 35762 Saint Grégoire, PA, BP 58, France
J Mol Cell Cardiol 33:1589-606. 2001..Altogether, our results show that S1P induces cardiomyocyte hypertrophy mainly via the EDG1 receptor and subsequently via Gi through ERKs, p38 MAPK, JNK, PI3K and via Rho pathway...
Activin can induce the formation of axial structures and is expressed in the hypoblast of the chickE Mitrani
Department of Zoology, Hebrew University of Jerusalem, Israel
Cell 63:495-501. 1990....
[Ion transporters and cardiovascular diseases: pH control or modulation of intracellular calcium concentration]A Bril
Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Experimentales, IFR 100, Facultés de Médecine et Pharmacie, 7, boulevard Jeanne d Arc, BP 87900, 21079 Dijon, France
Ann Cardiol Angeiol (Paris) 52:41-51. 2003..Therefore, inhibiting these transporters could represent novel therapeutic strategies for the treatment of cardiovascular diseases...
